Chinese Journal of Mycology 2011, Vol. 6 Issue (3): 180-185.
Previous Articles Next Articles
Received:2010-11-09
Online:2011-06-28
Published:2011-06-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/
http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/Y2011/V6/I3/180
| [1] Khan ZU,Randhawa HS,Kowshik T,et al.Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India[J].J Antimicrob Chemother,2007,60(2):312-316. [2] Souza LK,Fernandes Ode F,Kobayashi CC,et al.Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiania city,Goias,Brazil[J].Rev Inst Med Trop San Paulo,2005,47(5):253-256. [3] Khan ZU,Randhawa HS,Chehadeh W,et al.Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole[J].Int J Antimicrob Agents,2009,33(6):559-563. [4] Okabayashi K,Imaji M,Osumi T,et al.Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses[J].Nippon Ishinkin Gakkai Zasshi,2009,50(2):91-94. [5] Pfaller MA,Zhang J,Messer SA,et al.In vitro activities of voriconazole,fluconazole,and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa[J].Antimicrob Agents Chemother,1999,43(1):169-171. [6] Hoban DJ,Zhanel GG,Karlowsky JA.In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients[J].Antimicrob Agents Chemother,1999,43(6):1463-1464. [7] Mitsuyama J,Nomura N,Hashimoto K,et al.In vitro and in vivo antifungal activities of T-2307,a novel arylamidine[J].Antimicrob Agents Chemother,2008,52(4):1318-1324. [8] Pfaller MA,Diekema DJ,Gibbs DL,et al.Results from the ARTEMIS DISK Global Antifungal Surveillance Study,1997 to 2007:10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and variconazole determined by CLSI standardized disk diffusion testing[J].J Clin Microbial,2009,47(1):117-123. [9] Chandenier J,Adou-Bryn KD,Douchet C,et al.In vitro activity of amphotericin B,fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia[J].Eur J Clin Microbiol Infect Dis,2004,(6):506-508. [10] Perkins A,Gomez-Lopez A,Mellado E,et al.Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var.neoformans[J].J Antimicrob Chemother,2005,56(6):1144-1147. [11] Thompson GR,Wiederhold NP,Fothergill AW,et al.Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans[J].Antimicrob Agents Chemother,2009,53(1):309-311. [12] Yildiran ST,Fothergill AW,Sutton DA,et al.In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole,voriconazole and posaconazole(SCH56592)[J].Mycoses,2002,45(9-10):378-383. [13] Ana KF,Costa JJC,Sidrim RA.Urban Pigeons(Columba livia)as a Potential Source of Pathogenic Yeasts:A Focus on Antifungal Susceptibility of Cryptococcus Strains in Northeast Brazil[J].Mycopathologia,2010,169(3):207-213. [14] Patrick Schwarz.In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates[J].Antimicrob Agents Chemother,2003,3:3361-3364. [15] Chang WN,Huang CR,Lei CB,et al.Serotypes of elinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphoteriein B,flueonazole,and voriconazole[J].Jpn J Infect Dis,2004,57(3):113-115. [16] Souza LK,Fernandes Ode F,Kobayashi CC,et al.Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiania city,Goias,Brazil[J].Rev lnst Med Trop San Paulo,2005,47(5):253-256. [17] Hagen F,lllnait-Zaragozi MT,Bartlett KH,et al.In vitro antifungal susceptibilities and AFLP genotyping of a worldwide collection of 350 clinical,veterinary and environmental Cryptococcus gattii isolates.Antimicrob Agents Chemother,2010 Sep 20[Epub ahead of print]. [18] Martinez LR,Ntiamoah P,Gacser A,et al.Voriconazole inhibits melanization in Cryptococcus neoformans[J].Antimi-crob Agents Chemother,2007,51(12):4396-4400. [19] van Duin D,Cleare W,Zaragoza O,et al.Effects of voriconazole on Cryptococcus neoformans[J].Antimicrob Agents Chemother,2004,48(6):2014-2020. [20] Chiller T,Farrokhshad K,Brummer E,et al.Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils,monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans[J].Med Mycol,2002,40(1):21-26. [21] Kirkpatrick WR,Najvar LK,Bocanegra R,et al.New guinea pig model of cryptococcal meningitis[J].Antimicrob Agents Chemother,2007,51(8):3011-3013. [22] Serena C,Pastor FJ,Matine M,et al.Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection[J].J Antimicrob Chemother,2007,60(1):162-165. [23] Mavrogiorgos N,Zaragoza O,Casadevall A,et al.Efficacy of voriconazole in experimental Cryptococcus neoformans infection[J].Mycopathologia,2006,162(2):111-114. [24] Silva EG,Paula CR,Dias AL,et al.Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans[J].Mycopathologia,2010 Oct 24[Epub ahead of print]. [25] Cairo E,Pastor FJ,Rodriguez MM,et al.Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii[J].Antimicrob Agents Chemother,2010,54(10):4074-4077. [26] Perfect JR,Marr KA,Walsh TJ,et al.Voriconazole treatment for less common,emerging,or refractory fungal infections[J].Clin Infect Dis,2003,36:1122-1131. [27] Sabbatani S,Manfredi R,Pavoni M,et al.Voriconazole proves effective in long-term treatment of a cerebra] cryptococcoma in a chronic nephropathic HIV-negative patient,after fluconazole failure[J].Mycopathologia,2004,158(2):165-171. [28] Izumikawa K,Zhao Y,Motoshima K,et al.A case of pulmonary cryptococcosis fullowed by pleuritis in an apparently immunecompetent patient during fluconazole treatment[J].Med Mycol,2008,46(6):595-599. [29] Tschudin S,Elzi L,Mayr M,et al.Successful treatment of cryptococcal meningitis with voriconazole in a kidney transplant recipient[J].Int J Infect Dis,2006,10(3):17. [30] Carbonara S,Regazzi M,Ciracl E,et al.Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis[J].Ann Pharmacother,2009,43(5):978-984. [31] Bandettini R,Castagnola E,Calvillo M,et al.Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant[J].J Chemother,2009,21(1):108-109. [32] Jose IV,Jesus DC,Ferran S,et al.Management of endogenous cryptococcal endophthalmitis with voriconazole[J].Can J Ophthalmol,2009,44(6):e61-62. [33] Lu HZ.Voriconazole in an infant with cryptococcal meningitis[J].Chin Med J,2008,121(3):286-288. [34] 朱一飞,邹月丽,王敏,等,伏立康唑治疗隐球菌性脑膜炎三例报告[J].脑与神经疾病杂志,2008,16(6):669-670. [35] Saag MS,Graybill RJ,Larsen RA,et al.Practice Guidelines for the Management of Cryptococcal Disease[J].Clin Infect Dis,2000,30(4):710-718. |
| [1] | ZHU Xin-lin, HONG Nan, ZHANG Chao, PAN Wei-hua, CAI Liang-qi, LI Xiao-jing, CHEN Min, LIAO Wan-qing. Genotypic diversity of 11 Cryptococcus neoformans isolates from kidney transplantation patients with cryptococcosis [J]. Chinese Journal of Mycology, 2020, 15(6): 338-343. |
| [2] | ZHAO Jing-yu, LIU Yi-shu, FANG Wei, LIAO Wan-qing, WANG Gui-zhen, GU Ju-lin. Construction and identification of yeast two-hybrid cDNA library of Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2020, 15(3): 134-137. |
| [3] | HUANG Jin-bao, LI Hong-yan, LAN Chang-qing, LV Xiao, LIN Zhi-lai, WANG Xin-hang, ZHANG Hong-ying, ZOU Sheng-hua, WEN Heng. Clinical application and evaluation oftwo different methods for detection of cryptococcal capsular polysaccharide antigen in diagnosis and treatment of pulmonary cryptococcosis [J]. Chinese Journal of Mycology, 2019, 14(5): 264-269. |
| [4] | LAI Rui, SONG Ying, LIU Wei-you, YUAN Xiao-liang. Improvement of the purification method of cryptococcal capsular polysaccharide glucuronoxylomannan [J]. Chinese Journal of Mycology, 2019, 14(4): 228-231. |
| [5] | LEI Yan, FANG Wei, ZHANG Chao, LIAO Wan-qing. In vitro chessboard detection for anti-Cryptococcus effect of rattlerin and fluconazole [J]. Chinese Journal of Mycology, 2019, 14(2): 90-94. |
| [6] | DENG Dong-ling, KONG Qing-tao, ZHANG Yuan-yuan, YUAN Hong-shan, LIU Hui, SANG Hong. Prokaryotic expression of Cryptococcus neoformans laccase [J]. Chinese Journal of Mycology, 2018, 13(4): 208-212. |
| [7] | CHEN Yan-hui, YU Feng, BIAN Ze-yuan, HONG Jian-ming, ZHONG Qiao-shi, HANG Ya-ping, ZHANG Nan, HU Long-hua. Molecular epidemiology and clinical characteristics of 34 cases of cryptococcal infection in HIV patients [J]. Chinese Journal of Mycology, 2018, 13(3): 152-157. |
| [8] | . [J]. Chinese Journal of Mycology, 2017, 12(4): 244-247,256. |
| [9] | LI Ying-Fang, SANG Jun-Jun, LI Juan, JIANG Wei-Wei, LIAO Wan-Qing, PAN Wei-Hua. Effects of transforming growth factor on the function of macrophage against Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2017, 12(2): 65-68. |
| [10] | Yultuz·Xohrat, Kadirye·Kasim, WANG Xiao-dong, DENG Shu-wen, Prida·Abliz. Molecular identification and genotyping and in vitro drug sensitivity study of the first five clinical isolates of Cryptococcus neoformans in Xinjiang [J]. Chinese Journal of Mycology, 2016, 11(6): 327-331. |
| [11] | ZHENG Chong, WEN Hai, GUO Fang, FAN Yi-bin. The study of expression changes of VEGFR in mice brain tissue infected with Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2016, 11(5): 257-260. |
| [12] | QIU Tian wen, ZHU Hong-mei, WEN Hai. Cryptococcus traversal across the Blood-Brain Barrier though S100A10-dependent activation of urokinase-plasmin system [J]. Chinese Journal of Mycology, 2016, 11(3): 129-134. |
| [13] | LI Ying-fang, PAN Wei-hua. Pattern regcognition receptors and signaling pathways in Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2016, 11(1): 58-61. |
| [14] | ZHOU Zhao-jing, FANG Wei, PAN Wei-hua, LIAO Wan-qing. Effect of mandelic acid and its metabolism made on virulence of Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2015, 10(6): 328-331. |
| [15] | GUO Lan-fang, LIU Da-biao, ZHOU Meng-jie, HUA Teng-jiang. The effects of tetrandrine on Candida albicans biofilm and germ tube formation [J]. Chinese Journal of Mycology, 2015, 10(5): 276-278. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
